Date of Graduation
5-2022
Document Type
UAF Access Only - Thesis
Degree Name
Bachelor of Science
Degree Level
Undergraduate
Department
Biological Sciences
Advisor/Mentor
Thallapuranam, Suresh
Committee Member/Reader
Du, Yuchun
Committee Member/Second Reader
Ivey, Mack
Committee Member/Third Reader
Plavcan, Joseph M.
Abstract
Fibroblast growth factors (FGFs) are a family of heparin-binding proteins involved in important biological processes such as cell proliferation, angiogenesis, tumor growth, and wound healing. FGF proteins are often used for tissue regeneration, but are subject to thermal, chemical, and proteolytic denaturation causing loss of function before they can be utilized. A novel FGF1-FGF2 heterodimer was designed which can exhibit the cell proliferation properties of FGF1 and the angiogenesis properties of FGF2. Based on previous work from the Kumar Lab, three mutations (R136E, K126N, and Q54P) were created on the FGF1 subunit of the heterodimer to stabilize the heparin-binding pocket (HBP) of the molecule. The HBP is a cluster of positively charged residues located at the C-terminal end (residues K126 to Q141) of FGF1 which facilitates heparin binding. Studies have shown that inherent instability of FGF1 is largely contributed by the presence of the HBP. Introduction of negatively charged amino acids into the HBP through site directed mutagenesis proved to increase the stability of the protein in various studies. The R136E and K126N mutations replace positively charged arginine and lysine by negatively charged glutamate and polar asparagine in the HBP. This contributes to added stability in proven studies. The R136E mutation also eliminates susceptibility of FGF1 to thrombin digestion by altering a secondary cleavage site for thrombin. Q54P, the third mutation, creates a more compact molecule, serving to increase stability of the protein. Large-scale expression, purification, and characterization experiments were performed on the wildtype, R136E (single mutant), R136E/K126N (double mutant), and R136E/K126N/Q54P (triple mutant) FGF1-FGF2 heterodimers to compare their thermal, chemical, and proteolytic stability. The triple mutant heterodimer exhibited the greatest overall stability in the presence and absence of heparin when compared to the other variants.
Keywords
proteins; FGF; biochemistry
Citation
Lukhi, G. (2022). Design and Characterization of a Novel Fibroblast Growth Factor Dimer Variant. Biological Sciences Undergraduate Honors Theses Retrieved from https://scholarworks.uark.edu/biscuht/62